Novel Human FCGR1A Variants Affect CD64 Functions and Are Risk Factors for Sarcoidosis is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0.698. It has been cited 21 times, with 17 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0.234
From 11 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 17 citers.
National Institutes of Health
Grant: R21 AI125729
NHLBI NIH HHS
Grant: R21 HL117652
NIAID NIH HHS
Grant: R21 AI149395
National Institutes of Health
Grant: 1R21AI149395-01
Functions of CD177 as a novel IgG Fc receptor
National Institutes of Health
Grant: 1R21AI125729-01
High affinity IgG Fc receptor FcγRIA variants as novel genetic markers for sarcoidosis
FWCI
1.75
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals